Skip to main content
. Author manuscript; available in PMC: 2017 Aug 31.
Published in final edited form as: Br J Haematol. 2015 Jun 30;171(1):91–99. doi: 10.1111/bjh.13529

Figure 4.

Figure 4

TP53 expression by CD34-positive cells and survival. Patients with myelodysplastic syndrome with fibrosis and strong (3+) TP53 expression by CD34-positive cells had (A) significantly shorter overall survival (OS, p=0.0419) and (B) leukaemia-free survival (p=0.0428) in comparison to those without p53 expression in CD34-positive cells.